Home › Sindromi mielodisplastiche › New Jersey › Edison
Studi clinici su Sindromi mielodisplastiche a Edison, NJ
7 studi su Sindromi mielodisplastiche cercano partecipanti presso sedi a Edison e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
In reclutamentoFase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
In reclutamentoFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
In reclutamentoFase 1/2
- START New Jersey, East Brunswick · a 6 mi di distanza
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- Saint Peter's University Hospital, New Brunswick · a 3 mi di distanza
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · a 3 mi di distanza
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
In reclutamentoFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, New Brunswick · a 3 mi di distanza
Studi su Sindromi mielodisplastiche in altre città
- Houston, TX43 studi
- Baldwin Park, CA26 studi
- New York City, NY21 studi
- Seattle, WA21 studi
- Washington, DC20 studi
- Boston, MA19 studi
- Tampa, FL19 studi
- Miami, FL17 studi
- Columbus, OH14 studi
- Durham, NC14 studi
- Chicago, IL13 studi
- Atlanta, GA13 studi
Altri studi a Edison
- Cancro al seno68 studi
- Cancro del polmone non a piccole cellule47 studi
- Cancro (tutti i tipi)33 studi
- Cancro alla prostata29 studi
- Cancro colorettale23 studi
- Cancro ai polmoni23 studi
- Mieloma multiplo22 studi
- Cancro della vescica21 studi
- Cancro metastatico20 studi
- Cancro ovarico20 studi
- Leucemia mieloide acuta20 studi
- Cancro dell'endometrio19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.